LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

March 20, 2026

mental-health

LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

ONLY AVAILABLE IN PAID PLANS.

Originally reported by rutlandherald. Read more

Source: https://www.rutlandherald.com/news/business/livanova-receives-u-s-food-and-drug-administration-premarket-approval-for-aura6000-system-to-treat/article_8e89b049-38e4-56a6-bc2d-6746e6312e35.html